Jihane Khalife

<i>RUNX1</i> Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

Jason H. Mendler, Kati Maharry, Michael D. Radmacher et al. · Journal of Clinical Oncology · 2012 · 265 citations

Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia

Adrienne M. Dorrance, Paolo Neviani, Gregory Ferenchak et al. · Leukemia · 2015 · 120 citations · Full text

Nanoparticles, Nanomedicine, Engineering +9

Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting

Domenico Viola, Ada Donà, Enrico Caserta et al. · Leukemia · 2020 · 83 citations · Full text

Inflammation, Cancer Immunosurveillance, Autoimmune Disease +14

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

Jihane Khalife, Hanna S. Radomska, Ramasamy Santhanam et al. · Leukemia · 2015 · 79 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Microrna Detection +7

Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma

Enrico Caserta, Junie Chea, Megan Minnix et al. · Blood · 2018 · 69 citations · Full text